Pages that link to "Q40835286"
Jump to navigation
Jump to search
The following pages link to Structure-based inhibitors of HIV-1 protease (Q40835286):
Displaying 50 items.
- Bile pigments as HIV-1 protease inhibitors and their effects on HIV-1 viral maturation and infectivity in vitro (Q24530002) (← links)
- Virus maturation as a new HIV-1 therapeutic target (Q24642446) (← links)
- Molecular mechanisms for the conversion of zymogens to active proteolytic enzymes (Q24673104) (← links)
- A brief history of macromolecular crystallography, illustrated by a family tree and its Nobel fruits (Q26823889) (← links)
- Inhibition of the HIV-1 and HIV-2 proteases by a monoclonal antibody (Q27620967) (← links)
- Crystal structure of an in vivo HIV-1 protease mutant in complex with saquinavir: Insights into the mechanisms of drug resistance (Q27628785) (← links)
- 1.9 A x-ray study shows closed flap conformation in crystals of tethered HIV-1 PR (Q27629375) (← links)
- Structural basis of HIV-1 and HIV-2 protease inhibition by a monoclonal antibody (Q27635256) (← links)
- Lack of synergy for inhibitors targeting a multi-drug-resistant HIV-1 protease (Q27637329) (← links)
- Substrate shape determines specificity of recognition for HIV-1 protease: analysis of crystal structures of six substrate complexes (Q27638967) (← links)
- Effects of remote mutation on the autolysis of HIV-1 PR: X-ray and NMR investigations (Q27639084) (← links)
- Viability of a drug-resistant human immunodeficiency virus type 1 protease variant: structural insights for better antiviral therapy (Q27640250) (← links)
- Solution structure of the mature HIV-1 protease monomer: insight into the tertiary fold and stability of a precursor (Q27641889) (← links)
- Crystal Structure of Lysine Sulfonamide Inhibitor Reveals the Displacement of the Conserved Flap Water Molecule in Human Immunodeficiency Virus Type 1 Protease (Q27646453) (← links)
- Potent New Antiviral Compound Shows Similar Inhibition and Structural Interactions with Drug Resistant Mutants and Wild Type HIV-1 Protease † (Q27647185) (← links)
- Effect of the Active Site D25N Mutation on the Structure, Stability, and Ligand Binding of the Mature HIV-1 Protease (Q27649876) (← links)
- Targeting the open-flap conformation of HIV-1 protease with pyrrolidine-based inhibitors (Q27651746) (← links)
- Structure of the unbound form of HIV-1 subtype A protease: comparison with unbound forms of proteases from other HIV subtypes (Q27660028) (← links)
- Crystal Structures of Inhibitor Complexes of Human T-Cell Leukemia Virus (HTLV-1) Protease (Q27663017) (← links)
- Crystal structure of XMRV protease differs from the structures of other retropepsins (Q27666692) (← links)
- Synthesis, X-ray Analysis, and Biological Evaluation of a New Class of Stereopure Lactam-Based HIV-1 Protease Inhibitors (Q27677537) (← links)
- Extreme Entropy–Enthalpy Compensation in a Drug-Resistant Variant of HIV-1 Protease (Q27681237) (← links)
- Structures of Darunavir-Resistant HIV-1 Protease Mutant Reveal Atypical Binding of Darunavir to Wide Open Flaps (Q27683434) (← links)
- Effects of Hinge Region Natural Polymorphisms on Human Immunodeficiency Virus-1 Protease Structure, Dynamics and Drug-Pressure Evolution (Q27727967) (← links)
- Comparative analysis of the X-ray structures of HIV-1 and HIV-2 proteases in complex with CGP 53820, a novel pseudosymmetric inhibitor (Q27729772) (← links)
- Crystal structure of a tethered dimer of HIV-1 proteinase complexed with an inhibitor (Q27729870) (← links)
- Crystal structures of HIV-2 protease in complex with inhibitors containing the hydroxyethylamine dipeptide isostere (Q27730225) (← links)
- Crystal structure of human immunodeficiency virus (HIV) type 2 protease in complex with a reduced amide inhibitor and comparison with HIV-1 protease structures (Q27732012) (← links)
- Structure of HIV-1 protease with KNI-272, a tight-binding transition-state analog containing allophenylnorstatine (Q27732560) (← links)
- Improved cyclic urea inhibitors of the HIV-1 protease: synthesis, potency, resistance profile, human pharmacokinetics and X-ray crystal structure of DMP 450 (Q27733420) (← links)
- Potent HIV Protease Inhibitors Containing a Novel (Hydroxyethyl)amide Isostere (Q27740243) (← links)
- How glutaminyl-tRNA synthetase selects glutamine (Q27749684) (← links)
- Molecular recognition of cyclic urea HIV-1 protease inhibitors (Q27757042) (← links)
- Patient-specific simulation as a basis for clinical decision-making (Q28284852) (← links)
- A potent human immunodeficiency virus type 1 protease inhibitor, UIC-94003 (TMC-126), and selection of a novel (A28S) mutation in the protease active site (Q28344457) (← links)
- Antiviral properties of aminodiol inhibitors against human immunodeficiency virus and protease (Q28368090) (← links)
- Selection and analysis of human immunodeficiency virus type 1 variants with increased resistance to ABT-538, a novel protease inhibitor (Q28368263) (← links)
- Genotypic and phenotypic characterization of human immunodeficiency virus type 1 variants isolated from patients treated with the protease inhibitor nelfinavir. (Q28369030) (← links)
- Potency and selectivity of inhibition of human immunodeficiency virus protease by a small nonpeptide cyclic urea, DMP 323 (Q28369098) (← links)
- Design and synthesis of a novel series of HIV-1 protease inhibitors (Q28374773) (← links)
- Structure-based design of diaminopyranosides as a novel inhibitor core unit of HIV proteases (Q28376032) (← links)
- Comparison of inhibitor binding to feline and human immunodeficiency virus proteases: structure-based drug design and the resistance problem (Q28378131) (← links)
- Selection of multiple human immunodeficiency virus type 1 variants that encode viral proteases with decreased sensitivity to an inhibitor of the viral protease (Q28378274) (← links)
- Efficacy of constant infusion of A-77003, an inhibitor of the human immunodeficiency virus type 1 (HIV-1) protease, in limiting acute HIV-1 infection in vitro (Q28378785) (← links)
- Antiviral properties of palinavir, a potent inhibitor of the human immunodeficiency virus type 1 protease (Q28378879) (← links)
- Drug resistance during indinavir therapy is caused by mutations in the protease gene and in its Gag substrate cleavage sites (Q28379086) (← links)
- Antiviral and resistance studies of AG1343, an orally bioavailable inhibitor of human immunodeficiency virus protease (Q28379166) (← links)
- The universal statistical distributions of the affinity, equilibrium constants, kinetics and specificity in biomolecular recognition (Q28546498) (← links)
- The folding free-energy surface of HIV-1 protease: insights into the thermodynamic basis for resistance to inhibitors (Q30157397) (← links)
- Point mutations and sequence variability in proteins: redistributions of preexisting populations. (Q30327984) (← links)